Caxton Corporation’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Hold |
43,465
| – | – | 1.15% | 6 |
|
|
2025
Q1 | $82.6K | Hold |
43,465
| – | – | 1.63% | 6 |
|
|
2024
Q4 | $63K | Hold |
43,465
| – | – | 0.38% | 10 |
|
|
2024
Q3 | $80K | Hold |
43,465
| – | – | 0.33% | 10 |
|
|
2024
Q2 | $43.5K | Hold |
43,465
| – | – | 0.22% | 10 |
|
|
2024
Q1 | $86.1K | Hold |
43,465
| – | – | 0.49% | 10 |
|
|
2023
Q4 | $67.8K | Sell |
43,465
-43,308
| -50% | -$67.6K | 0.37% | 11 |
|
|
2023
Q3 | $171K | Buy |
86,773
+43,307
| +100% | +$85.3K | 0.65% | 6 |
|
|
2023
Q2 | $138K | Sell |
43,466
-168,274
| -79% | -$535K | 0.4% | 5 |
|
|
2023
Q1 | $675K | Buy |
211,740
+581
| +0.3% | +$1.85K | 1.71% | 9 |
|
|
2022
Q4 | $1.06M | Buy |
+211,159
| New | +$1.06M | 2.71% | 10 |
|